• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 435574 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1419036128 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1419036128 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Illumina Bearish Moving Average Crossover Alert (ILMN)

Published on Mon, 02/04/2013 - 12:13
By Mallory Stone

Today, shares of Illumina (NASDAQ:ILMN) have crossed bearishly below their 10-day moving average of $50.98 on a volume of 460K shares. This may provide swing traders with an opportunity for a short position, as such a crossover often suggests lower prices in the near term.

In the past 52 weeks, Illumina share prices have been bracketed by a low of $25.57 and a high of $79.40 and are now at $50.63, 98% above that low price. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.4%.

Illumina has overhead space with shares priced $50.63, or 7.7% below the average consensus analyst price target of $54.88. The stock should hit resistance at its 50-day moving average (MA) of $52.53, as well as support at its 200-day MA of $46.32.

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Shares of Wells Fargo Rise to a New 52-W...

Wells Fargo (NYSE:WFC) traded at a new 52-week high today of $55.42. Approximately 20. ...

Watch for Continued Gains in Shares of W...

Wisconsin Energy (NYSE:WEC) traded today at a new 52-week high of $52.50. So far today ...

Recent 52-Week High Exceeded in Shares o...

Shares of Western Digital (NYSE:WDC) traded today at $114.69, breaking its 52-week high ...

WellCare Health Plans: The Winning Strea...

Shares of WellCare Health Plans (NYSE:WCG) traded at a new 52-week high today of $80.95 ...

Vertex Pharmaceuticals Looks to Continue...

Vertex Pharmaceuticals (NASDAQ:VRTX) traded at a new 52-week high today of $123.82. Th ...

Shares of Vornado Realty Trust Rise Abov...

Shares of Vornado Realty Trust (NYSE:VNO) traded today at $117.37, breaking its 52-week ...

US Bancorp Looks to Continue to Trade Ab...

Shares of US Bancorp (NYSE:USB) traded today at $45.54, breaking its 52-week high. So ...

United Parcel Service Looks to Continue ...

United Parcel Service (NYSE:UPS) traded today at a new 52-week high of $111.99. So far ...